Armata Pharmaceuticals (ARMP) Short Interest Ratio & Short Volume → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free ARMP Stock Alerts $4.18 +0.08 (+1.95%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Armata Pharmaceuticals Short Interest DataCurrent Short Volume13,300 sharesPrevious Short Volume29,600 sharesChange Vs. Previous Month-55.07%Dollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover0.6Last Record DateMarch 15, 2024Outstanding Shares36,150,000 sharesFloat Size10,720,000 sharesShort Percent of Float0.12%Today's Trading Volume35,815 sharesAverage Trading Volume18,271 sharesToday's Volume Vs. Average196% Short Selling Armata Pharmaceuticals ? Sign up to receive the latest short interest report for Armata Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatARMP Short Interest Over TimeARMP Days to Cover Over TimeARMP Percentage of Float Shorted Over Time Ad Prosper Trading AcademyDid you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy Armata Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202413,300 shares $0.00 -55.1%0.1%0.6 $0.00 2/29/202429,600 shares $0.00 -32.0%0.3%1.5 $0.00 2/15/202443,500 shares $0.00 -5.2%0.4%2.4 $0.00 1/31/202445,900 shares $0.00 -17.9%0.4%2.6 $0.00 1/15/202455,900 shares $0.00 -31.1%0.5%3.2 $0.00 12/31/202381,100 shares $0.00 -18.2%0.8%5 $0.00 Get the Latest News and Ratings for ARMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Armata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/15/202399,100 shares $0.00 +9.4%0.9%7.1 $0.00 11/30/202390,600 shares $0.00 -8.3%0.8%5.1 $0.00 11/15/202398,800 shares $0.00 -0.9%0.9%4.4 $0.00 10/31/202399,700 shares $0.00 -25.4%0.9%2.6 $0.00 10/15/2023133,700 shares $0.00 -19.6%1.2%1 $0.00 9/30/2023166,200 shares $0.00 -4.3%1.5%0.9 $0.00 9/15/2023173,700 shares $0.00 -6.8%1.6%1 $0.00 8/31/2023186,300 shares $0.00 -11.8%1.7%1.1 $0.00 8/15/2023211,100 shares $0.00 -21.5%1.9%1.3 $0.00 7/31/2023268,800 shares $0.00 +688.3%2.5%1.8 $0.00 7/15/202334,100 shares $0.00 +14.8%0.3%0.7 $0.00 6/30/202329,700 shares $0.00 +13.4%0.3%4 $0.00 6/15/202326,200 shares $0.00 +19.6%0.2%3.4 $0.00 5/31/202321,900 shares $0.00 No Change0.2%2.3 $0.00 5/15/202321,900 shares $0.00 -41.8%0.2%1.7 $0.00 4/30/202337,600 shares $0.00 +15.7%0.3%2.9 $0.00 4/15/202332,500 shares $0.00 +18.6%0.3%2.1 $0.00 3/31/202327,400 shares $0.00 -21.5%0.3%1.6 $0.00 3/15/202334,900 shares $0.00 +52.4%0.3%1.6 $0.00 2/28/202322,900 shares $0.00 -3.0%0.2%1 $0.00 2/15/202323,600 shares $0.00 -9.2%0.2%1.1 $0.00 1/31/202326,000 shares $0.00 -31.8%0.2%1.2 $0.00 1/15/202338,100 shares $0.00 +45.4%0.4%1.9 $0.00 12/30/202226,200 shares $0.00 -51.1%0.2%1.5 $0.00 12/15/202253,600 shares $0.00 +31.1%0.5%3.7 $0.00 11/30/202240,900 shares $0.00 -14.6%0.4%4.4 $0.00 11/15/202247,900 shares $0.00 -14.2%0.4%7.5 $0.00 10/31/202255,800 shares $0.00 -12.4%0.5%10.3 $0.00 10/15/202263,700 shares $0.00 -3.0%0.6%15.2 $0.00 9/30/202265,700 shares $0.00 -17.2%0.6%16.4 $0.00 9/15/202279,300 shares $0.00 +7.0%0.7%20.9 $0.00 8/31/202274,100 shares $0.00 +1.7%0.7%19 $0.00 8/15/202272,900 shares $0.00 +0.6%0.7%18.7 $0.00 7/31/202272,500 shares $0.00 -1.0%0.7%15.4 $0.00Did you make $29,000 two days with AI options trades? (Ad)What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy ARMP Short Interest - Frequently Asked Questions What is Armata Pharmaceuticals' current short interest? Short interest is the volume of Armata Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 13,300 shares of ARMP short. 0.12% of Armata Pharmaceuticals' shares are currently sold short. Learn More on Armata Pharmaceuticals' current short interest. What is a good short interest ratio for Armata Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARMP shares currently have a short interest ratio of 1.0. Learn More on Armata Pharmaceuticals's short interest ratio. Which institutional investors are shorting Armata Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Armata Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Armata Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.12% of Armata Pharmaceuticals' floating shares are currently sold short. Is Armata Pharmaceuticals' short interest increasing or decreasing? Armata Pharmaceuticals saw a decrease in short interest in March. As of March 15th, there was short interest totaling 13,300 shares, a decrease of 55.1% from the previous total of 29,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Armata Pharmaceuticals' float size? Armata Pharmaceuticals currently has issued a total of 36,150,000 shares. Some of Armata Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Armata Pharmaceuticals currently has a public float of 10,720,000 shares. How does Armata Pharmaceuticals' short interest compare to its competitors? 0.12% of Armata Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Armata Pharmaceuticals: BioAtla, Inc. (10.70%), DBV Technologies S.A. (0.28%), Molecular Partners AG (0.13%), Cellectis S.A. (1.22%), Xtant Medical Holdings, Inc. (0.43%), bluebird bio, Inc. (31.13%), aTyr Pharma, Inc. (0.43%), Cardiol Therapeutics Inc. (0.44%), Genfit S.A. (0.20%), Sangamo Therapeutics, Inc. (6.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Armata Pharmaceuticals stock? Short selling ARMP is an investing strategy that aims to generate trading profit from Armata Pharmaceuticals as its price is falling. ARMP shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Armata Pharmaceuticals? A short squeeze for Armata Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ARMP, which in turn drives the price of the stock up even further. How often is Armata Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARMP, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BioAtla Short Squeeze DBV Technologies Short Squeeze Molecular Partners Short Squeeze Cellectis Short Squeeze Xtant Medical Short Squeeze bluebird bio Short Squeeze aTyr Pharma Short Squeeze Cardiol Therapeutics Short Squeeze Genfit Short Squeeze Sangamo Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:ARMP) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets